Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Federica Crispino"'
Publikováno v:
VideoGIE, Vol 7, Iss 12, Pp 427-431 (2022)
Externí odkaz:
https://doaj.org/article/579a363707cf4fe4a119930af153f72d
Autor:
Emanuele Sinagra, Anita Busacca, Laura Guida, Lucio Carrozza, Daniele Brinch, Federica Crispino, Marcello Maida, Salvatore Battaglia, Ciro Celsa, Calogero Cammà, Maria Cappello
Publikováno v:
Gastroenterology Insights, Vol 13, Iss 1, Pp 117-126 (2022)
Background: The COVID-19 outbreak has led IBD clinics to adopt a remote monitoring approach in order to guarantee an adequate follow-up of patients with inflammatory bowel disease (IBD) and ensure the rules of social distancing. Aim: The aim of the s
Externí odkaz:
https://doaj.org/article/493f3e7aae984486b79719a900cbdd42
Autor:
Emanuele Sinagra, Endrit Shahini, Federica Crispino, Ina Macaione, Valentina Guarnotta, Marta Marasà, Sergio Testai, Socrate Pallio, Domenico Albano, Antonio Facciorusso, Marcello Maida
Publikováno v:
Life, Vol 12, Iss 9, p 1292 (2022)
The outbreak of COVID-19, initially developed in China in early December 2019, has rapidly spread to other countries and represents a public health emergency of international concern. COVID-19 has caused great concern about respiratory symptoms, but
Externí odkaz:
https://doaj.org/article/0c19ad47ad0f41018bde1dc9b6db9b65
Autor:
Fabio Salvatore Macaluso, Marcello Maida, Mauro Grova, Federica Crispino, Giulia Teresi, Adele Orlando, Ambrogio Orlando
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
During past years, the increasing knowledge of molecular mechanisms of inflammatory bowel disease (IBD) have led to the development of several targeted biological therapies. This great expansion of available medical options has prompted the need for
Externí odkaz:
https://doaj.org/article/e5b82e07be2048d09ae84a323e274de2
Autor:
Federica Crispino, Elettra Merola, Enrico Tasini, Calogero Cammà, Vito di Marco, Giovanni de Pretis, Andrea Michielan
Publikováno v:
Digestive and Liver Disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bae245d7f0e3aab8efd87a1f1e74e78
https://doi.org/10.1016/j.dld.2023.04.007
https://doi.org/10.1016/j.dld.2023.04.007
Autor:
Mauro Grova, Federica Crispino, Marcello Maida, Alessandro Vitello, Sara Renna, Angelo Casà, Lorenzo Tesè, Fabio Salvatore Macaluso, Ambrogio Orlando
Publikováno v:
Digestive and Liver Disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3411529448715e01728ef47a3a14adc
https://doi.org/10.1016/j.dld.2023.02.017
https://doi.org/10.1016/j.dld.2023.02.017
Autor:
Fabio Salvatore Macaluso, Maria Cappello, Federica Crispino, Mauro Grova, Antonino Carlo Privitera, Giovita Piccillo, Antonio Magnano, Concetta Ferracane, Nunzio Belluardo, Emiliano Giangreco, Walter Fries, Anna Viola, Roberto Di Mitri, Filippo Mocciaro, Salvatore Camilleri, Serena Garufi, Sara Renna, Angelo Casà, Marcello Maida, Ambrogio Orlando
Publikováno v:
Digestive and Liver Disease. 54:629-634
The role of Vedolizumab (VDZ) as therapeutic option for the postoperative recurrence of Crohn's disease (CD) following ileocolonic resection is unknown.To assess the effectiveness of VDZ in this setting.All consecutive CD patients with a baseline col
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e79f3a52c44f7f88dfc726a820024a56
https://doi.org/10.1016/j.dld.2021.11.021
https://doi.org/10.1016/j.dld.2021.11.021
Autor:
Mauro Grova, Federica Crispino, Marcello Maida, Sara Renna, Mariella Mannino, Angelo Casà, Giulia Rizzuto, Fabio Salvatore Macaluso, Ambrogio Orlando
Publikováno v:
European Journal of Gastroenterology & Hepatology. 34:607-612
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b0fea7b1d83e8e5a807c83df0b1ccfd
https://doi.org/10.1097/meg.0000000000002348
https://doi.org/10.1097/meg.0000000000002348
Autor:
Sandro Sferrazza, Federica Crispino, Filippo Vieceli, Andrea Fiorentino, Andrea Michielan, Giovanni de Pretis
Publikováno v:
Endoscopy. 55:E645-E646
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f8535b5e9aa018ec7254cd84b29b098
https://doi.org/10.1055/a-2058-8202
https://doi.org/10.1055/a-2058-8202
Autor:
A. Casà, Mauro Grova, Fabio Salvatore Macaluso, Filippo Mocciaro, Daniela Scimeca, Sara Renna, Federica Crispino, Ambrogio Orlando, Giulia Rizzuto, Roberto Di Mitri, Marcello Maida, Lorenzo Tesè
Publikováno v:
Expert Opinion on Biological Therapy. 21:1133-1141
There is a growing need for biomarkers to predict therapeutic outcome in Crohn's disease (CD).The aim was to evaluate whether NLR (neutrophil-to-lymphocyte ratio), PLR (platelet-to-lymphocyte ratio), ELR (eosinophil-to-lymphocyte ratio), and ENLR (eo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d89eae0f17156b7f9808d264deb5b983
https://doi.org/10.1080/14712598.2021.1935857
https://doi.org/10.1080/14712598.2021.1935857